Cenobamate

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 304 publications

Redefining the treatment pathway for medication-resistant epilepsy in the cenobamate era: Surgical obviation or surgical delay.

Redefining the treatment pathway for medication-resistant epilepsy in the cenobamate era: Surgical obviation or surgical delay.

Journal: Epilepsia
Published: March 10, 2026

Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.

Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.

Journal: JAMA neurology
Published: February 09, 2026

Effectiveness of adjunctive low-dose clobazam in adults with focal drug-resistant epilepsy and incomplete response to cenobamate: A real-world study.

Effectiveness of adjunctive low-dose clobazam in adults with focal drug-resistant epilepsy and incomplete response to cenobamate: A real-world study.

Journal: Epilepsia open
Published: January 28, 2026

Polysubstance overdose with cenobamate, levetiracetam and clobazam: Insights into cenobamate toxicity.

Polysubstance overdose with cenobamate, levetiracetam and clobazam: Insights into cenobamate toxicity.

Journal: Seizure
Published: January 27, 2026

Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy.

Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy.

Journal: Pharmaceutics
Published: December 24, 2025

Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment.

Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment.

Journal: Epilepsy & behavior : E&B
Published: December 19, 2025

Pharmacokinetic variability and complex two-way interactions with cenobamate in patients with refractory epilepsy.

Pharmacokinetic variability and complex two-way interactions with cenobamate in patients with refractory epilepsy.

Journal: Epilepsia
Published: December 19, 2025

Long-term outcomes of responsive neurostimulation in dominant-hemisphere Rasmussen encephalitis.

Long-term outcomes of responsive neurostimulation in dominant-hemisphere Rasmussen encephalitis.

Journal: Acta neurologica Belgica
Published: December 12, 2025

Delayed and deferred surgery associated with cenobamate use in people with drug-resistant focal epilepsy.

Delayed and deferred surgery associated with cenobamate use in people with drug-resistant focal epilepsy.

Journal: Epilepsia
Published: December 11, 2025

Early Cenobamate as a Third-Line Option in Drug-Resistant Focal Epilepsy: A Paradigm Shift?

Early Cenobamate as a Third-Line Option in Drug-Resistant Focal Epilepsy: A Paradigm Shift?

Journal: Neurology and therapy
Published: December 05, 2025

Long-Term Impact of Cenobamate on Cognition, Adaptive Behavior, and Quality of Life in Patients with Tuberous Sclerosis Complex.

Long-Term Impact of Cenobamate on Cognition, Adaptive Behavior, and Quality of Life in Patients with Tuberous Sclerosis Complex.

Journal: Neurology and therapy
Published: December 05, 2025

Adjunctive Use of Cenobamate in Paediatric Drug-Resistant Epilepsy: A Real-World, Single-Centre Experience.

Adjunctive Use of Cenobamate in Paediatric Drug-Resistant Epilepsy: A Real-World, Single-Centre Experience.

Journal: Journal of clinical medicine
Published: December 05, 2025
Showing 1-12 of 304

Last Updated: 04/28/2026